Prism Medico And Pharmacy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/02/2026 inter alia to consider and approve - Consider and discuss alteration in the Articles of Association of the company subject to approval of shareholders.- Consider and discuss the proposal for fund raising by way of preferential issue/private placement of securities for cash including determination of issue price subject to such regulatory/statutory approvals as may be required including the approval of shareholders of the company. - Consider and discuss any other routine matter or business of the company. Further we wish to inform that in pursuance of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 and Companys Code of Conduct for Regulating Monitoring and Reporting of Trading by Insiders the Trading Window for dealing in the shares of the company shall closed for all Designated Person and their immediate relatives from the date of this letter i.e. February 18 2026 till 48 hours from the conclusion of the Board Meeting.
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]